Genevieve Ening
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Genevieve Ening has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Kirsten Schmieder
Department of Neurosurgery, University Medical Center Langendreer, Ruhr-University-Bochum, Bochum, Germany
6 shared publicationsChristopher Brenke
Department of Neurosurgery, University Medical Center Langendreer, Ruhr-University-Bochum, Bochum, Germany
5 shared publications- David Capper
Department of Neuropathology Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany
3 shared publications - Andrey Korshunov
Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany
1 shared publication Anne Carolus
Department of Neurosurgery, University Medical Center Langendreer, Ruhr-University-Bochum, Bochum, Germany
1 shared publicationAnnika Kowoll
Department of Radiology and Neuroradiology, University Medical Center Langendreer, Ruhr-University-Bochum, Bochum, Germany
1 shared publication
Latest Publications
- 1 March 2016
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 142, 38-42
Radiological and clinical results of patients after ACDF with and without preoperative software-assisted cage selection
- 1 March 2016
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 142, 38-42
Radiological and clinical results of patients after ACDF with and without preoperative software-assisted cage selection
- 1 December 2015
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 139, 278-281
Lumbar juxta-facet joint cysts in association with facet joint orientation, -tropism and -arthritis: A case–control study
- 1 December 2015
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 139, 278-281
Lumbar juxta-facet joint cysts in association with facet joint orientation, -tropism and -arthritis: A case–control study
- 3 November 2015
- Published by Georg Thieme Verlag KG in Neurochirurgie Scan
- Vol. 03 (04) , 291-301
Management spinaler Metastasen: ein Update
Die chirurgische Therapie von Wirbelsäulenmetastasen ist aufgrund des verlängerten und vor allem des verbesserten Überlebens von Tumorpatienten durch neuere tumorspezifische Therapien zu einem festen Bestandteil des operativen Spektrums geworden.
- 3 November 2015
- Published by Georg Thieme Verlag KG in Neurochirurgie Scan
- Vol. 03 (04) , 291-301
Management spinaler Metastasen: ein Update
Die chirurgische Therapie von Wirbelsäulenmetastasen ist aufgrund des verlängerten und vor allem des verbesserten Überlebens von Tumorpatienten durch neuere tumorspezifische Therapien zu einem festen Bestandteil des operativen Spektrums geworden.
- 1 September 2015
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 136, 89-94
Repeat-surgery at Glioblastoma recurrence, when and why to operate?
- 1 September 2015
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 136, 89-94
Repeat-surgery at Glioblastoma recurrence, when and why to operate?
- 1 July 2015
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 134, 55-59
Risk factors for glioblastoma therapy associated complications
- 1 July 2015
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 134, 55-59
Risk factors for glioblastoma therapy associated complications
- 11 January 2015
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 141 (6) , 1131-1137
Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification
Dismal glioblastoma (GB) patient outcome calls for the elucidation of further reliable predictors of prognosis. Established “biomarkers,” age and functional status, employed in today’s patient stratification have limits in fingerprinting this heterogeneous tumor entity. We aimed at ascertaining additional prognostic factors that may facilitate patient stratification for surgery. A retrospective review of 233 consecutive adult patients operated on for newly diagnosed GB at a single tertiary institution over a 5-year period (2006–2011) was conducted. Modern defined outcome associating factors recorded included demographics (preoperative age, gender, signs, symptoms, comorbidity status quantified by the Charlson comorbidity index (CCI), functional status computed by the Karnofsky performance scale (KPS)), tumor characteristics (size, location, isocitrate dehydrogenase mutation, and O-6-methylguanine-DNA methyltransferase promoter methylation status), and treatment parameters (volumetrically quantified extent of resection and adjuvant therapy). Survival analysis was performed by the Kaplan–Maier method. Influence of variables was evaluated using log-rank test. Median neuroradiographic evidence of tumor progression was 6 months after surgery (range 0–72). The median overall survival was 9.5 months (range 0–72). Age > 65 years, KPS ≤ 70, and CCI > 3 were significantly associated with both poor OS (each p < 0.0001) and PFS (p < 0.0001, p < 0.001 and p < 0.002), respectively. Also, patients older than 65 years significantly had a CCI > 3 (p < 0.0001). Our data evidence that aside established prognostic parameters (age and KPS) for GB patient outcome, the CCI additionally significantly impacts outcome and may be employed for preoperative patient stratification.
- 11 January 2015
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 141 (6) , 1131-1137
Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification
Dismal glioblastoma (GB) patient outcome calls for the elucidation of further reliable predictors of prognosis. Established “biomarkers,” age and functional status, employed in today’s patient stratification have limits in fingerprinting this heterogeneous tumor entity. We aimed at ascertaining additional prognostic factors that may facilitate patient stratification for surgery. A retrospective review of 233 consecutive adult patients operated on for newly diagnosed GB at a single tertiary institution over a 5-year period (2006–2011) was conducted. Modern defined outcome associating factors recorded included demographics (preoperative age, gender, signs, symptoms, comorbidity status quantified by the Charlson comorbidity index (CCI), functional status computed by the Karnofsky performance scale (KPS)), tumor characteristics (size, location, isocitrate dehydrogenase mutation, and O-6-methylguanine-DNA methyltransferase promoter methylation status), and treatment parameters (volumetrically quantified extent of resection and adjuvant therapy). Survival analysis was performed by the Kaplan–Maier method. Influence of variables was evaluated using log-rank test. Median neuroradiographic evidence of tumor progression was 6 months after surgery (range 0–72). The median overall survival was 9.5 months (range 0–72). Age > 65 years, KPS ≤ 70, and CCI > 3 were significantly associated with both poor OS (each p < 0.0001) and PFS (p < 0.0001, p < 0.001 and p < 0.002), respectively. Also, patients older than 65 years significantly had a CCI > 3 (p < 0.0001). Our data evidence that aside established prognostic parameters (age and KPS) for GB patient outcome, the CCI additionally significantly impacts outcome and may be employed for preoperative patient stratification.
- Open Access
- 1 January 2015
- Published by Scitechnol Biosoft Pvt. Ltd. in Journal of Neurology and Neuroscience
- Vol. 06 (02)
Adjunct Perioperative Factors Impacting Brain Metastasis Patient’s Morbidity and Mortality
Background: Brain metastasis (BM), occur more frequently as therapy for primary tumors improve and patients survive longer. Neurosurgeons are hence challenged with perioperative patient management and adequate stratification. This study aimed at identifying additional preoperative stratification parameters impacting patient morbidity and mortality. Methods and findings: A retrospective review of 100 adult patients operated for BM within 18 months at a single institution was conducted. Clinical records of patients were evaluated for outcome associating factors, recording demographics, tumor characteristics and treatment parameters. Survival analysis was performed by the Kaplan-Meier-method. Parameters affecting perioperative mortality and morbidity were examined using univariate and multivariate cox proportionalhazards regression models. For the 43 female and 57 male patients the median age was 64 years (range 45- 82). Median body mass index (BMI) was 24.7 kg/m2 (range 14.7-39.9). Mean serum C-reactive protein (CRP) level was 2 ± 0.3 mg/L with 43% of patients having elevated levels. In-hospital mortality rate was 4% and complication rate was 29% (41 cases; 9 surgical, 11 neurological and 21 medical). Recurrence rated with 8%. Significant variables for improved survival were non-occurrence of complications (p=0.001), age <65 years (p=0.024), and solitary BM (p=0.007). This reflected in high recursive partitioning analysis (RPA) classes (p<0.0001) significantly impacting poor survival. RPA class (p<0.001, OR 3.52, 95% CI 1.80-6.90) and complication occurrence (p=0.05, OR 2.36, 95% CI 1.30-4.28) independently impacted poor survival. None of the assessed parameters including BMI, CRP and Charlson-comorbidity-index (CCI) proved significantly associated with complication occurrence. Conclusions: Our results support the prognostic significance of the RPA classification and proves complication occurrence to significantly impact poor survival. CCI, BMI and CRP did not significantly impact mortality or morbidity. Hence, they may not be eligible parameters for selecting surgical patients.
- 1 January 2015
- Published by Scitechnol Biosoft Pvt. Ltd. in Journal of Neurology and Neuroscience
- Vol. 06 (02)
Open AccessAdjunct Perioperative Factors Impacting Brain Metastasis Patient’s Morbidity and Mortality
Background: Brain metastasis (BM), occur more frequently as therapy for primary tumors improve and patients survive longer. Neurosurgeons are hence challenged with perioperative patient management and adequate stratification. This study aimed at identifying additional preoperative stratification parameters impacting patient morbidity and mortality. Methods and findings: A retrospective review of 100 adult patients operated for BM within 18 months at a single institution was conducted. Clinical records of patients were evaluated for outcome associating factors, recording demographics, tumor characteristics and treatment parameters. Survival analysis was performed by the Kaplan-Meier-method. Parameters affecting perioperative mortality and morbidity were examined using univariate and multivariate cox proportionalhazards regression models. For the 43 female and 57 male patients the median age was 64 years (range 45- 82). Median body mass index (BMI) was 24.7 kg/m2 (range 14.7-39.9). Mean serum C-reactive protein (CRP) level was 2 ± 0.3 mg/L with 43% of patients having elevated levels. In-hospital mortality rate was 4% and complication rate was 29% (41 cases; 9 surgical, 11 neurological and 21 medical). Recurrence rated with 8%. Significant variables for improved survival were non-occurrence of complications (p=0.001), age <65 years (p=0.024), and solitary BM (p=0.007). This reflected in high recursive partitioning analysis (RPA) classes (p<0.0001) significantly impacting poor survival. RPA class (p<0.001, OR 3.52, 95% CI 1.80-6.90) and complication occurrence (p=0.05, OR 2.36, 95% CI 1.30-4.28) independently impacted poor survival. None of the assessed parameters including BMI, CRP and Charlson-comorbidity-index (CCI) proved significantly associated with complication occurrence. Conclusions: Our results support the prognostic significance of the RPA classification and proves complication occurrence to significantly impact poor survival. CCI, BMI and CRP did not significantly impact mortality or morbidity. Hence, they may not be eligible parameters for selecting surgical patients.
- 1 November 2014
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 21 (11) , 1945-1950
Spinal metastasis of gliosarcoma: Array-based comparative genomic hybridization for confirmation of metastatic spread
- 1 November 2014
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 21 (11) , 1945-1950
Spinal metastasis of gliosarcoma: Array-based comparative genomic hybridization for confirmation of metastatic spread